Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Efpia Medicine Private Limited is an Indian pharmaceutical company specializing in the PCD (Propaganda-Cum-Distribution) Pharma Franchise model and third-party manufacturing. Established in 2024 and headquartered in Panchkula, Haryana, the company offers a vast portfolio of over 1,600 DCGI-approved products, including tablets, capsules, injections, and syrups. Efpia Medicine provides monopoly-based distribution rights and comprehensive marketing support to its franchise partners across India. Its product range covers diverse therapeutic areas such as cardiology, diabetology, neurology, dermatology, and nephrology. The company emphasizes quality through WHO-GMP and ISO 9001:2015 certified manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Efpia Medicine.